International Immunology Advance Access originally published online on September 22, 2009
International Immunology 2009 21(11):1301; doi:10.1093/intimm/dxp101
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Japanese Society for Immunology. 2009. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org
correction |
Anti-vascular endothelial growth factor (VEGF) specific activity of intravenous immunoglobulin (IVIg)
1 Department of Medicine B, Center for Autoimmune Diseases, Sheba Medical Center, Sackler Faculty of Medicine, Tel-Aviv University, Tel-Hashomer, Israel
2 Felsenstein Medical Research Center, Sackler Faculty of Medicine, Tel-Aviv University, Rabin Medical Center, Beilinson Campus, Petah Tikva, Israel
3 Incumbent of Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Israel
| The first 10% of the full text of this article appears below. |
International Immunology, Vol. 21, pp. 1057–1063.
The authors wish to